SecBot SecBot
SECBOTREPLAY Home › Report › TXG

TXG · 10x Genomics appointed Ansuman Satpathy, a Stanford professor and…

10x Genomics, Inc. · 8-K filed Nov 2, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Nov 2, 2026 at 16:05 ET

10x Genomics appointed Ansuman Satpathy, a Stanford professor and venture partner, and Joseph Gilliam, President/COO of Glaukos Corporation, to its Board of Directors as Class III directors effective October 28, 2026. Gilliam was also appointed Chair of the Audit Committee. This is a routine board expansion with no departure of existing officers.

  • Ansuman Satpathy and Joseph Gilliam appointed to the Board of Directors as Class III directors effective October 28, 2026.
  • Satpathy is an Associate Professor at Stanford and a venture partner at Wing Venture Capital; Gilliam is President/COO of Glaukos Corporation.
  • Joseph Gilliam appointed Chair of the Audit Committee on October 30, 2026, with an additional annual retainer of $25,000.
  • Each new director receives standard non-employee director compensation: $60,000 annual cash retainer, a one-time RSU grant of $400,000, and annual RSU grants of $215,000.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access